Neurocrine Biosciences (NBIX) Profit After Tax (2010 - 2026)
Neurocrine Biosciences (NBIX) posted quarterly Profit After Tax of $149.1 million for Q2 2026, up 34.32% year-over-year from $111.0 million in Q2 2025, and down 24.66% on a QoQ basis from $197.9 million in Q1 2026.
Neurocrine Biosciences (NBIX) Profit After Tax (2010 - 2026) Analysis & Trends
Neurocrine Biosciences has reported Profit After Tax for 17 years, with the latest figure at $149.1 million in Q2 2026.
- Profit After Tax for Q2 2026 came in at $149.1 million, up 34.32% year-over-year; the trailing twelve-month figure through Jun 2026 was $710.8 million (up 97.72% YoY), and the FY2025 annual result was $485.9 million, up 42.37% from the prior year.
- Profit After Tax slipped to $149.1 million in Q2 2026, from $197.9 million in the prior quarter.
- Over five years, Profit After Tax peaked at $210.2 million in Q3 2025 and troughed at -$76.6 million in Q1 2023.
- A 5-year average of $88.4 million and a median of $92.3 million in 2022 frame the typical range for Profit After Tax.
- The widest annual swing landed in 2023, when Profit After Tax slumped 651.08%; it then soared 1682.88% in 2026.
- A 5-year view of Profit After Tax shows it stood at $89.0 million in 2022, then surged by 75.73% to $156.4 million in 2023, then plunged by 38.87% to $95.6 million in 2024, then jumped by 60.67% to $153.6 million in 2025, then declined by 2.93% to $149.1 million in 2026.
- Per Business Quant data, the three most recent Profit After Tax figures were $149.1 million in Q2 2026, $197.9 million in Q1 2026, and $153.6 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.80 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.05 Bn | 39.39 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.51 Bn | 29.84 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.70 Bn | 22.90 Bn | 5.10 Bn | 710.56 Mn |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.83 Bn | 17.95 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.06 Bn | 11.53 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.27 Bn | 7.61 Bn | 397.90 Mn | 501,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 149.10 Mn |
| Mar 31, 2026 | 197.90 Mn |
| Dec 31, 2025 | 161.00 Mn |
| Sep 30, 2025 | 210.20 Mn |
| Jun 30, 2025 | 107.50 Mn |
| Mar 31, 2025 | 11.10 Mn |
| Dec 31, 2024 | 94.40 Mn |
| Sep 30, 2024 | 129.80 Mn |
| Jun 30, 2024 | 65.00 Mn |
| Mar 31, 2024 | 39.70 Mn |
| Dec 31, 2023 | 162.60 Mn |
| Sep 30, 2023 | 82.50 Mn |
| Jun 30, 2023 | 95.50 Mn |
| Mar 31, 2023 | -76.60 Mn |
| Dec 31, 2022 | 85.70 Mn |
| Sep 30, 2022 | 68.50 Mn |
| Jun 30, 2022 | -19.80 Mn |
| Mar 31, 2022 | 13.90 Mn |
| Dec 31, 2021 | -5.90 Mn |
| Sep 30, 2021 | 22.50 Mn |